Eloxx Pharmaceuticals Inc.
ELOX | NASDAQ
$12.77
-$0.68 (-5.06%)
Nov 2, 2026, 2:29 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 61.96M | 6.36M | 4.99M | 4.54M | 5.17M | 19.47M | 24.82M | 30.31M | 40.07M | 42.57M | 52.68M | 56.98M | 18.3M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 849K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 211K | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.43M | 44K | 137K | 107K | 259K | 202K | 325K | 413K | 602K | 377K | 369K | 545K | 433K |
Total Current Assets | 63.39M | 7.65M | 5.63M | 5.38M | 6.4M | 20.13M | 25.67M | 31.59M | 42.15M | 43.48M | 53.33M | 58.56M | 19.96M |
Property-Plant & Equipment | n/a | n/a | 413K | 611K | 797K | 994K | 1.21M | 1.35M | 1.47M | 1.66M | 1.84M | 2.05M | 406K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | 849K | 413K | 611K | 797K | 994K | 1.21M | 1.35M | 1.47M | 1.66M | 2.05M | 2.05M | 406K |
Total Assets | 63.39M | 8.5M | 6.04M | 5.99M | 7.2M | 21.12M | 26.88M | 32.94M | 43.62M | 45.14M | 55.38M | 60.61M | 20.37M |
Account Payables | 3.03M | 3.03M | 3.13M | 3.12M | 2.43M | 3.02M | 1.6M | 1.93M | 2.9M | 1.38M | 2.51M | 2.02M | 485K |
Deferred Revenue | n/a | 11.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 3.13M | 2.77M | 2.2M | 4.69M | 3.23M | 1.81M | 647K | 657K | 667K | 6.44M | 5.84M |
Other Current Liabilities | 13.94M | n/a | 17.08M | 15.22M | 14.68M | 14.63M | 16.37M | 15.29M | 15.1M | 6.3M | 5.15M | 5.7M | 5.64M |
Total Current Liabilities | 16.97M | 16.09M | 23.47M | 21.25M | 19.46M | 23.09M | 21.68M | 19.5M | 19.17M | 9.96M | 9.51M | 15.21M | 12.69M |
Long-Term Debt | n/a | n/a | 2.62M | 3.33M | 4.03M | 8.56M | 9.86M | 11.13M | 12.12M | 12M | 11.91M | 3.64M | 4.91M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | 2.62M | 3.34M | 4.03M | 8.69M | 10.18M | 11.63M | 12.76M | 12.8M | 12.88M | 4.76M | 4.92M |
Total Liabilities | 16.97M | 16.09M | 26.09M | 24.59M | 23.49M | 31.78M | 31.86M | 31.13M | 31.93M | 22.76M | 22.39M | 19.97M | 17.62M |
Total Debt | n/a | n/a | 5.76M | 6.11M | 6.24M | 13.38M | 13.41M | 13.44M | 13.41M | 13.46M | 13.54M | 11.2M | 10.77M |
Book Value | 46.42M | -7.58M | -20.05M | -18.6M | -16.29M | -10.66M | -4.98M | 1.81M | 11.69M | 22.38M | 33M | 40.64M | 2.75M |
Book Value Per Share | 6.84 | -1.73 | -57.95 | -74.45 | -81.01 | -54.13 | -25.30 | 9.20 | 59.34 | 113.66 | 168.07 | 207.44 | 18.23 |
Common Stock | 40K | 51K | 31K | 25K | 22K | 22K | 871K | 871K | 871K | 871K | 863K | 863K | 404K |
Retained Earnings | -308.84M | -304.33M | -288.55M | -284.96M | -280.62M | -274.39M | -268.07M | -260.56M | -249.94M | -238.32M | -226.23M | -216.35M | -180.29M |
Comprehensive Income | n/a | n/a | n/a | -41K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 46.42M | -7.58M | -20.05M | -18.6M | -16.29M | -10.66M | -4.98M | 1.81M | 11.69M | 22.38M | 33M | 40.64M | 2.75M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ELOX